A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Central Nervous System Lymphoma
Related studies linked through entity extraction aliases.
Loncastuximab Tesirine and Rituximab Following Stereotactic Radiosurgery in Patients With Central Nervous System Lymphomas (SOLAR)
- Status
- RECRUITING
- Phase
- PHASE1
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
- Status
- RECRUITING
- Phase
- N/A
Human CD19-CD22 Targeted T Cells Injection for Refractory/Relapsed Central Nervous System Leukemia/Lymphoma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous System Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Acalabrutinib in CNSL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
DALY II USA/ MB-CART2019.1 for DLBCL
- Status
- RECRUITING
- Phase
- PHASE2
A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2